We will be giving Erwinia asparaginase IV instead of IM for the first time next week as per the option in COG AAML1831. Are there any different monitoring guidelines, has anybody seen an increase in adverse reactions with the IV route? There is the option to give IM in the protocol, but if it’s all the same I’d rather not give an IM injection
Elizabeth Sonnenblick, CPHON,CPNP,MSN,RN
St Joseph’s Regional Medical Center
Log in to reply.